That's because patients who receive specialist care and consistent follow-up are more likely to stay on track
However, even with intensive lowering of LDL cholesterol, patients remain at high residual risk because of low HDL cholesterol and/or elevated triglycerides, justifying the need for additional therapy specifically aimed at the management of these abnormalities [3]
doi: 10.1038/nm.4102 119 QuintanaFJBassoASIglesiasAHKornTFarezMFBettelliEet al
Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, Emerson SS, Kahn SE, Kitzman DW, Lingvay I, Mahaffey KW, Petrie MC, Plutzky J, Rasmussen S, Rnnbck C, Shah SJ, Verma S, Weeke PE, Lincoff AM, SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators (2024) Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
Patients receive a baseline metabolic profile that helps providers tailor medication selection and dosing
Comparing weight-loss data U.S